Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Medtronic Talent Thoracic Stent Graft with Captivia Delivery System, for use in the endovascular repair of thoracic aortic aneurysms (TAA).
Subscribe to our email newsletter
The Talent Captivia System is indicated specifically for the endovascular repair of fusiform aneurysms and saccular aneurysms/penetrating ulcers of the descending thoracic aorta in patients having appropriate anatomy.
In addition to tip caputure, the Talent Captivia System features a hydrophilic coating to ease insertion into the femoral artery and navigation through the iliac arteries (around the pelvis) en route to the aorta.
The University of Pennsylvania Hospital System vice-chief and Vascular Surgery and Endovascular Therapy program director Edward Woo said that the Captivia delivery system’s tip capture mechanism is designed to provide excellent control of the stent graft during deployment to ensure that blood flow isn’t occluded into the nearby arteries.